PMC:7534795 / 114400-114670 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T91","span":{"begin":49,"end":54},"obj":"Body_part"},{"id":"T92","span":{"begin":141,"end":156},"obj":"Body_part"},{"id":"T93","span":{"begin":223,"end":229},"obj":"Body_part"},{"id":"T94","span":{"begin":230,"end":235},"obj":"Body_part"}],"attributes":[{"id":"A91","pred":"fma_id","subj":"T91","obj":"http://purl.org/sig/ont/fma/fma67264"},{"id":"A92","pred":"fma_id","subj":"T92","obj":"http://purl.org/sig/ont/fma/fma49893"},{"id":"A93","pred":"fma_id","subj":"T93","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A94","pred":"fma_id","subj":"T94","obj":"http://purl.org/sig/ont/fma/fma67264"}],"text":"he potential for COVID-19 infection to alter the lipid profile acutely and the association of dyslipidemia with conditions such as diabetes, coronary artery disease, and obesity raises the question whether normalization of plasma lipid profiles in COVID-19 patients can "}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T154","span":{"begin":141,"end":156},"obj":"Body_part"},{"id":"T155","span":{"begin":150,"end":156},"obj":"Body_part"}],"attributes":[{"id":"A154","pred":"uberon_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/UBERON_0001621"},{"id":"A155","pred":"uberon_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/UBERON_0001637"}],"text":"he potential for COVID-19 infection to alter the lipid profile acutely and the association of dyslipidemia with conditions such as diabetes, coronary artery disease, and obesity raises the question whether normalization of plasma lipid profiles in COVID-19 patients can "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T631","span":{"begin":17,"end":25},"obj":"Disease"},{"id":"T632","span":{"begin":26,"end":35},"obj":"Disease"},{"id":"T633","span":{"begin":94,"end":106},"obj":"Disease"},{"id":"T634","span":{"begin":131,"end":139},"obj":"Disease"},{"id":"T635","span":{"begin":141,"end":164},"obj":"Disease"},{"id":"T636","span":{"begin":150,"end":164},"obj":"Disease"},{"id":"T637","span":{"begin":170,"end":177},"obj":"Disease"},{"id":"T638","span":{"begin":248,"end":256},"obj":"Disease"}],"attributes":[{"id":"A631","pred":"mondo_id","subj":"T631","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A632","pred":"mondo_id","subj":"T632","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A633","pred":"mondo_id","subj":"T633","obj":"http://purl.obolibrary.org/obo/MONDO_0002525"},{"id":"A634","pred":"mondo_id","subj":"T634","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A635","pred":"mondo_id","subj":"T635","obj":"http://purl.obolibrary.org/obo/MONDO_0005010"},{"id":"A636","pred":"mondo_id","subj":"T636","obj":"http://purl.obolibrary.org/obo/MONDO_0000473"},{"id":"A637","pred":"mondo_id","subj":"T637","obj":"http://purl.obolibrary.org/obo/MONDO_0011122"},{"id":"A638","pred":"mondo_id","subj":"T638","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"he potential for COVID-19 infection to alter the lipid profile acutely and the association of dyslipidemia with conditions such as diabetes, coronary artery disease, and obesity raises the question whether normalization of plasma lipid profiles in COVID-19 patients can "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T153","span":{"begin":150,"end":156},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"T154","span":{"begin":150,"end":156},"obj":"http://www.ebi.ac.uk/efo/EFO_0000814"},{"id":"T155","span":{"begin":223,"end":229},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"he potential for COVID-19 infection to alter the lipid profile acutely and the association of dyslipidemia with conditions such as diabetes, coronary artery disease, and obesity raises the question whether normalization of plasma lipid profiles in COVID-19 patients can "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T68916","span":{"begin":49,"end":54},"obj":"Chemical"},{"id":"T74078","span":{"begin":230,"end":235},"obj":"Chemical"}],"attributes":[{"id":"A24443","pred":"chebi_id","subj":"T68916","obj":"http://purl.obolibrary.org/obo/CHEBI_18059"},{"id":"A48745","pred":"chebi_id","subj":"T74078","obj":"http://purl.obolibrary.org/obo/CHEBI_18059"}],"text":"he potential for COVID-19 infection to alter the lipid profile acutely and the association of dyslipidemia with conditions such as diabetes, coronary artery disease, and obesity raises the question whether normalization of plasma lipid profiles in COVID-19 patients can "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T258","span":{"begin":94,"end":106},"obj":"Phenotype"},{"id":"T259","span":{"begin":170,"end":177},"obj":"Phenotype"}],"attributes":[{"id":"A258","pred":"hp_id","subj":"T258","obj":"http://purl.obolibrary.org/obo/HP_0003119"},{"id":"A259","pred":"hp_id","subj":"T259","obj":"http://purl.obolibrary.org/obo/HP_0001513"}],"text":"he potential for COVID-19 infection to alter the lipid profile acutely and the association of dyslipidemia with conditions such as diabetes, coronary artery disease, and obesity raises the question whether normalization of plasma lipid profiles in COVID-19 patients can "}

{"project":"LitCovid-PubTator","denotations":[{"id":"3230","span":{"begin":257,"end":265},"obj":"Species"},{"id":"3242","span":{"begin":49,"end":54},"obj":"Chemical"},{"id":"3243","span":{"begin":230,"end":235},"obj":"Chemical"},{"id":"3263","span":{"begin":17,"end":25},"obj":"Disease"},{"id":"3264","span":{"begin":26,"end":35},"obj":"Disease"},{"id":"3265","span":{"begin":94,"end":106},"obj":"Disease"},{"id":"3266","span":{"begin":131,"end":139},"obj":"Disease"},{"id":"3267","span":{"begin":141,"end":164},"obj":"Disease"},{"id":"3268","span":{"begin":170,"end":177},"obj":"Disease"},{"id":"3269","span":{"begin":248,"end":256},"obj":"Disease"}],"attributes":[{"id":"A3230","pred":"tao:has_database_id","subj":"3230","obj":"Tax:9606"},{"id":"A3242","pred":"tao:has_database_id","subj":"3242","obj":"MESH:D008055"},{"id":"A3243","pred":"tao:has_database_id","subj":"3243","obj":"MESH:D008055"},{"id":"A3263","pred":"tao:has_database_id","subj":"3263","obj":"MESH:C000657245"},{"id":"A3264","pred":"tao:has_database_id","subj":"3264","obj":"MESH:D007239"},{"id":"A3265","pred":"tao:has_database_id","subj":"3265","obj":"MESH:D050171"},{"id":"A3266","pred":"tao:has_database_id","subj":"3266","obj":"MESH:D003920"},{"id":"A3267","pred":"tao:has_database_id","subj":"3267","obj":"MESH:D003324"},{"id":"A3268","pred":"tao:has_database_id","subj":"3268","obj":"MESH:D009765"},{"id":"A3269","pred":"tao:has_database_id","subj":"3269","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"he potential for COVID-19 infection to alter the lipid profile acutely and the association of dyslipidemia with conditions such as diabetes, coronary artery disease, and obesity raises the question whether normalization of plasma lipid profiles in COVID-19 patients can "}